Citigroup Inc. Has $7.44 Million Stock Position in Amdocs Limited (NASDAQ:DOX)

Citigroup Inc. increased its position in Amdocs Limited (NASDAQ:DOX) by 59.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,477 shares of the technology company’s stock after purchasing an additional 51,241 shares during the quarter. Citigroup Inc. owned 0.10% of Amdocs worth $7,439,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the company. Lunia Capital LP purchased a new position in shares of Amdocs in the fourth quarter valued at $20,647,000. FMR LLC boosted its stake in Amdocs by 9.3% during the 4th quarter. FMR LLC now owns 18,209,169 shares of the technology company’s stock valued at $1,066,693,000 after acquiring an additional 1,543,698 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Amdocs by 7.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 6,903,063 shares of the technology company’s stock valued at $404,382,000 after acquiring an additional 456,936 shares during the last quarter. Wells Fargo & Company MN boosted its stake in Amdocs by 28.1% during the 1st quarter. Wells Fargo & Company MN now owns 5,951,683 shares of the technology company’s stock valued at $322,045,000 after acquiring an additional 1,303,903 shares during the last quarter. Finally, BlackRock Inc. boosted its stake in Amdocs by 3.7% during the 4th quarter. BlackRock Inc. now owns 4,031,466 shares of the technology company’s stock valued at $236,162,000 after acquiring an additional 142,470 shares during the last quarter. Institutional investors and hedge funds own 91.54% of the company’s stock.

Shares of Amdocs stock traded down $0.21 during trading hours on Monday, reaching $61.88. The company’s stock had a trading volume of 495,304 shares, compared to its average volume of 1,039,585. The business’s 50 day moving average price is $60.32. Amdocs Limited has a one year low of $52.60 and a one year high of $69.16. The stock has a market capitalization of $8.64 billion, a PE ratio of 16.55, a P/E/G ratio of 1.82 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings results on Tuesday, May 14th. The technology company reported $1.06 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.03 by $0.03. Amdocs had a net margin of 8.96% and a return on equity of 15.18%. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period last year, the firm posted $0.95 EPS. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. Equities research analysts forecast that Amdocs Limited will post 4.01 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 19th. Investors of record on Friday, June 28th will be issued a $0.285 dividend. The ex-dividend date is Thursday, June 27th. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.84%. Amdocs’s dividend payout ratio (DPR) is presently 30.48%.

A number of research analysts have commented on DOX shares. TheStreet upgraded shares of Amdocs from a “c+” rating to a “b-” rating in a research note on Tuesday, June 4th. Zacks Investment Research upgraded shares of Amdocs from a “hold” rating to a “buy” rating and set a $68.00 price objective on the stock in a research note on Friday, May 17th. BidaskClub upgraded shares of Amdocs from a “sell” rating to a “hold” rating in a research note on Tuesday, June 11th. ValuEngine upgraded shares of Amdocs from a “sell” rating to a “hold” rating in a research note on Wednesday, May 15th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Amdocs from $70.00 to $67.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 15th. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $71.40.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

Featured Story: How to track put option volume

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.